News

Zimmer Biomet and OneStep Join Forces for Enhanced Recovery Insights

Zimmer Biomet and OneStep Join Forces for Enhanced Recovery Insights

Zimmer Biomet and OneStep Team Up for Patient Recovery Innovation

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a leader in medical technology, recently announced a groundbreaking partnership with OneStep. OneStep is renowned for its FDA-listed mobility intelligence platform. The goal of this collaboration is to offer orthopedic surgeons comprehensive mobility data, which will help track patients' recovery progress after joint replacement surgeries. By leveraging data, both companies aim to empower patients to take an active role in their recovery process.

Integration of Mobility Data for Enhanced Recovery

Through this collaboration, OneStep's clinically validated analytics will be integrated into Zimmer Biomet's mymobility Care Management Platform. This integration will allow orthopedic surgery patients to access valuable insights directly from their smartphones, promoting a seamless recovery journey. Patients can gather data from their surgical preparation stage all the way through to their recovery, all while using just their mobile devices.

Transforming Patient Engagement with Technology

Robert Kraal, vice president and general manager of Connected Health at Zimmer Biomet, emphasized the significance of this partnership, stating, "This partnership represents a significant step forward in connecting surgical innovation with patient engagement and functional outcomes. By incorporating OneStep's advanced analytics, we can personalize recovery while ensuring minimal burden on both patients and clinicians."

Advancements in Connected Care Strategy

This integration aligns with Zimmer Biomet's broader vision for connected care, intertwining technology, data, and digital resources across the entire patient journey. Using data analysis from over a million gait cycles daily, OneStep offers a vast real-world mobility dataset, enabling Zimmer Biomet to monitor trends, quantify functional progress, and personalize rehabilitation efforts based on objective insights.

Empowering Patients with Meaningful Data

Tomer Shussman, CEO of OneStep, expressed enthusiasm about the partnership, stating, "Zimmer Biomet has set the standard for digital orthopedic care, and our mobility intelligence aligns perfectly with their vision of enhancing patient outcomes." Together, they aim to transform mobility into a vital sign, providing both patients and providers with critical data to optimize healthcare delivery.

Comprehensive Care with the mymobility Platform

The mymobility Care Management Platform is designed to provide an efficient orthopedic experience for patients, offering a variety of features. These include education, check-ins, messaging, video-guided exercises, and mobility metrics analysis. The platform also supports telehealth applications, automating data collection and insights for surgeons to enhance patient care.

As a leader in integrating technology into healthcare, Zimmer Biomet continually advances its offerings to maximize patient mobility and improve health outcomes. With over 90 years of experience, the company is dedicated to innovation, transforming patient experiences through its expansive portfolio of products and robotics.

About Zimmer Biomet and OneStep

Zimmer Biomet is committed to delivering high-quality medical solutions to patients and healthcare providers globally. Operating in over 25 countries and achieving sales in more than 100, Zimmer Biomet utilizes data analytics and artificial intelligence to enhance patient care.

OneStep serves as an innovative platform that turns any smartphone into a movement sensor, capturing essential metrics on gait, balance, and mobility. Its applications extend beyond orthopedics to prevent falls and monitor chronic conditions, showing the potential of technology in healthcare.

Frequently Asked Questions

What is the purpose of the Zimmer Biomet and OneStep collaboration?

The collaboration aims to enhance recovery monitoring for orthopedic surgery patients by integrating advanced mobility data into healthcare platforms.

How does mymobility enhance patient recovery?

The mymobility platform provides patients with access to their mobility data and insights directly on their smartphones, guiding them through their recovery process.

Who is Robert Kraal?

Robert Kraal is the vice president and general manager of Connected Health at Zimmer Biomet, playing a pivotal role in the integration of technology into patient care.

What is OneStep's mobility intelligence?

OneStep's mobility intelligence captures data on gait and mobility, helping to track patient progress and personalize care plans based on real-world insights.

How long has Zimmer Biomet been in the medical technology field?

Zimmer Biomet has over 90 years of experience in the medical technology industry, focusing on improving patient mobility and health outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 185

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 148

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Civista Welcomes Healthcare Leader to Boost Growth

Updated Category News Views 145

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 58

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 115

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

IO Biotech Secures Substantial Debt Financing to Advance Cancer Vaccines

Updated Category News Views 218

Introduction to IO Biotech's Recent Financing IO Biotech, a prominent clinical-stage biopharmaceutical firm, has recently taken a significant step towards enhancing its financial capacity. This move comes in the form of a loan of up to €57.5 million from the European Investment Bank (EIB), an institution dedicated to boosting sustainable ventures within the European...

Continue Reading
Gold Prices Surge: Mining Companies Expand Potential with Rising Markets

Updated Category News Views 247

Gold Prices Remain Elevated As gold prices stabilize above $4,100 per ounce, the mining industry is experiencing unprecedented profit margins. Recent trends in the market indicate significant growth, with a notable increase in activity among exploration and development companies. Buyers and investors alike are capitalizing on the bullish climate within the precious metals...

Continue Reading
Esperion's Strong Q2 2025 Results Highlight Growth Strategy

Updated Category News Views 148

Esperion Celebrates Impressive Growth in Q2 2025 Esperion (NASDAQ: ESPR) recently reported significant financial results for the second quarter ended June 30, 2025, demonstrating a robust year-over-year performance and a commitment to advancing its cardiovascular therapies. Total revenue reached $82.4 million, reflecting a 12% growth as compared to the same period in...

Continue Reading
Understanding the Shift in AMD Options Trading Dynamics

Updated Category News Views 196

What’s Happening with AMD Options Trading? Advanced Micro Devices (NASDAQ: AMD) continues to draw significant attention from high-value investors who appear to be optimistic about the company's future. Recent trades suggest that these investors are adopting a bullish stance, a clear signal for retail traders to take notice. Interpreting Unusual Options Activity...

Continue Reading
Growing Demand for Ternary Cathode NCM Materials in EVs

Updated Category News Views 105

Understanding the Ternary Cathode NCM Material Market The global Ternary Cathode NCM Material market is experiencing significant growth due to a surge in demand for electric vehicle (EV) batteries. Initially valued at approximately USD 9.156 billion, this market is projected to reach an impressive USD 28.65 billion by 2031, reflecting a robust compound annual growth rate...

Continue Reading